11-24-2014	Obeticholic acid promising against NASH liver damage
11-20-2014	Drug spending tops $1 trln on hepatitis C, cancer therapies -study
11-11-2014	Interferon-free regimen works against HCV in liver recipients
11-11-2014	AbbVie, Enanta drug shows potential in hep C genotype 4 patients
11-10-2014	INSIGHT-After hep C cure, companies target next big liver disease market
11-03-2014	Sofosbuvir-ledipasvir effective for relapsed HCV-1
09-30-2014	France uses tax to put pressure on hepatitis C drug prices
09-22-2014	Smartphone app may allow parents to screen newborns for jaundice
09-17-2014	Gilead's pancreas cancer drug fails mid-stage study
09-03-2014	Triptolide nanoformulation targets liver cancer cells
08-27-2014	ANALYSIS-InterMune drug may offer big upside to Roche if aimed at liver
08-15-2014	Achillion's hepatitis C drug cures all patients in mid-stage trial
08-12-2014	Intercept drug for non-alcoholic steatohepatitis found effective
08-06-2014	High HCV response rates with daclatasvir/asunaprevir: phase III data
07-23-2014	Gilead hepatitis C drug Sovaldi racks up $3.5 bln in quarter
07-16-2014	Lanreotide slows progression of neuroendocrine tumors
07-11-2014	Senators ask Gilead to explain cost of Sovaldi hepatitis drug
07-07-2014	Japan approves all-oral hepatitis C dual drug regimen
06-17-2014	AbbVie all-oral hepatitis C therapy gets rapid EU review
06-13-2014	AbbVie says hepatitis C regimen gets nod for FDA priority review
06-11-2014	Lilly's Cyramza fails in liver cancer trial
05-16-2014	Drug for alpha-1 antitrypsin deficiency fails key trial
04-22-2014	Drug combination shows more efficacy against hepatitis C
04-14-2014	Drug for primary biliary cirrhosis proves highly effective in study
04-11-2014	Doctors welcome hepatitis C drug rivals
04-10-2014	Bristol-Myers hepatitis C treatment cures up to 90%: study
03-20-2014	Geron says FDA halts patient enrollment in another cancer trial
03-17-2014	Primary biliary cirrhosis drug effective in third late-stage trial
03-11-2014	Bayer's Nexavar misses target in liver cancer trial
03-04-2014	Dynavax withdraws EU marketing application for Hep B vaccine
03-04-2014	Panel favors continuation of tivantinib study for liver cancer
03-04-2014	Drug for nonalcoholic steatosis meets main goal in study
12-18-2013	Stellar hepatitis C data puts Gilead farther ahead of pack
12-10-2013	AbbVie says most in hepatitis C study show improvement